Supreme Court questions how far generics makers can go with 'skinny label' drugs

Nicole DeFeudis for Endpoints News April 30, 2026 02:10 PM EDT PharmaLaw Supreme Court ques­tions how far gener­ics mak­ers can go when mar­ket­ing 'skin­ny la­bel' drugs Nicole DeFeudis Senior Reporter WASH­ING­TON — Supreme Court jus­tices gave a few hints about how they in­tend to rule in a di­vi­sive case for the phar­ma­ceu­ti­cal in­dus­try. In its fi­nal … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER